Establishment of magnetic resonance (MR) diagnostic criterion of prostate cancer

Application of magnetic resonance(MR) in diagnosis of prostate cancer

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-DDT-09000570

Enrollment

Unknown

Registered

2009-11-01

Start date

2008-12-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Gold Standard:

Index test:

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Male with no age restricts; 2. Able and willing to provide signed inform consent; 3. No contraindication of MR examination; 4. Suspicion of prostate cancer: A. PSA>4ng/dl; B. Nodule touched by digital examination of rectum; C. Abnormal echoes detected by ultrasound, prostate cancer suspected.

Exclusion criteria

Exclusion criteria: 1. Mild range or sever renal injury, GFR/eGFR144mmol/l; 3. Allergies or allergic to the contrast media

Design outcomes

Primary

Measure	Time frame
Lesion existence;Accuracy;Sensitivity;Specificity;Lesion malignanc;	—

Countries

China

Contacts

Public ContactXiaoying Wang

cjr.wangxiaoying@vip.163.com+86 10 83572097

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026